AU2021901673A0 - Macular telangiectasia type 2 treatment - Google Patents

Macular telangiectasia type 2 treatment

Info

Publication number
AU2021901673A0
AU2021901673A0 AU2021901673A AU2021901673A AU2021901673A0 AU 2021901673 A0 AU2021901673 A0 AU 2021901673A0 AU 2021901673 A AU2021901673 A AU 2021901673A AU 2021901673 A AU2021901673 A AU 2021901673A AU 2021901673 A0 AU2021901673 A0 AU 2021901673A0
Authority
AU
Australia
Prior art keywords
treatment
macular telangiectasia
telangiectasia type
type
macular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2021901673A
Inventor
Thomas Llewelyn Edwards
Doron Geoffrey Hickey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre for Eye Research Australia
Original Assignee
Centre for Eye Research Australia
Filing date
Publication date
Application filed by Centre for Eye Research Australia filed Critical Centre for Eye Research Australia
Publication of AU2021901673A0 publication Critical patent/AU2021901673A0/en
Assigned to CENTRE FOR EYE RESEARCH AUSTRALIA LTD reassignment CENTRE FOR EYE RESEARCH AUSTRALIA LTD Amend patent request/document other than specification (104) Assignors: CENTRE FOR EYE RESEARCH AUSTRALIA LTD.
Priority to PCT/AU2022/050550 priority Critical patent/WO2022251923A1/en
Abandoned legal-status Critical Current

Links

AU2021901673A 2021-06-04 2021-06-04 Macular telangiectasia type 2 treatment Abandoned AU2021901673A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2022/050550 WO2022251923A1 (en) 2021-06-04 2022-06-03 Macular telangiectasia type 2 treatment

Publications (1)

Publication Number Publication Date
AU2021901673A0 true AU2021901673A0 (en) 2021-06-17

Family

ID=

Similar Documents

Publication Publication Date Title
EP3998990A4 (en) Myopia progression treatment
EP4123081A4 (en) Clothing treatment apparatus
EP4190959A4 (en) Clothing treatment device
EP4117655A4 (en) Treatment methods
EP4039327A4 (en) Blood treatment material
EP4090369A4 (en) Pericyte-sparing therapy
EP4008696A4 (en) Surface treatment agent
EP4017490A4 (en) Compounds and methods for treating oxalate-related diseases
EP4001364A4 (en) Surface treatment agent
AU2021901673A0 (en) Macular telangiectasia type 2 treatment
EP4061411A4 (en) Methods for providing continuous therapy against pnag comprising microbes
EP3995554A4 (en) Surface treatment agent
EP3733102A4 (en) Medical treatment tool
EP3941453A4 (en) Therapeutic methods and compositions for treating lymphoma using 6,8-bis-benzylthio-octanoic acid
AU2020900782A0 (en) Treatment Methods
AU2021904108A0 (en) Treating COVID
AU2021900569A0 (en) Animal Treatment
AU2022902522A0 (en) Treating Myopia
AU2022902521A0 (en) Treating Myopia
AU2022900124A0 (en) Treating COVID
EP3941395A4 (en) Corneal treatment
EP4098263A4 (en) Treatment for chondrodystrophia
WO2022117171A9 (en) Diathermy 120-160w
EP3960143A4 (en) Treatment table
AU2019904863A0 (en) Cancer treatment (2)